pdatanews238
event5 outcomes

When will the FDA approve Compass Pathways' COMP360 Psilocybin?

Kalshi·Science and Technology·ends Jan 8, 2028

As of 03:21 UTC on 5 Nov 2026, the highest-priced of the 5 markets in “When will the FDA approve Compass Pathways' COMP360 Psilocybin?” on Kalshi are “Before 2028” at 92%, “Before July 2027” at 86% and “Before October 2027” at 83%. The event has $209 in Kalshi-reported 24-hour volume. pdata.world compares it with 24 related events on Kalshi, Polymarket and Manifold.

vol cum
$26.3k
vol 24h
$209
outcomes
5
ends
Jan 8, 2028
outcomesclick to inspect →
marketselected outcome
Before 2028
rank #1
United States
92¢
vol cum
$1.1k
vol 24h
$0
spread
0.12
ends
Jan 8, 2028

If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jan 1, 2028, then the market resolves to Yes.

timeline
opened · Mar 24, 2026opencloses · Jan 8, 2028
Before 2028 · prices over time
−24h
now
volume · by outcomehover a column to inspect
no volume history

similar markets

suggested by pdata